Aurelia Bihari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aurelia Bihari has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Gediminas Cepinskas
Lawson Health Research Institute, London, Canada
5 shared publications Abdel-Rahman Lawendy
Department of Surgery (Chohan, Bihari, Schemitsch, Sanders, Lawendy), Schulich School of Medicine, University of Western Ontario; Division of Orthopaedic Surgery (Bihari, Tieszer, MacNevin, Schemitsch, Sanders, Lawendy) and Perioperative Services (Churcher, Vandersluis, Cassar), and Department of Anaesthesia (Lin), London Health Sciences Centre, London, Ont
4 shared publicationsRichard F. Potter
Centre for Critical Illness Research, Lawson Health Research Institute, London, Ontario, Canada; Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada
4 shared publications- Abdel-Rahman Lawendy
Division of Orthopaedic Surgery, Western University, London, ON, Canada; Centre for Critical Illness Research, Victoria Hospital, London, ON, Canada
2 shared publications Abdel-Rahman MD Lawendy
Division of Orthopaedic Surgery, University of Western Ontario
2 shared publicationsDavid Md Sanders
Division of Orthopaedic Surgery, University of Western Ontario
2 shared publications
Latest Publications
- 10 May 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (4) , 041001
Cytotoxicity of novel hybrid composite materials for making bone fracture plates
Bone fracture plates are usually made from steel or titanium, which are much stiffer than cortical bone. This may cause bone ‘stress shielding’ (i.e. bone resorption leading to plate loosening) and delayed fracture healing (i.e. fracture motion is less than needed to stimulate callus formation at the fracture). Thus, the authors previously designed, fabricated, and mechanically tested novel ‘hybrid’ composites made from inorganic and organic materials as potential bone fracture plates that are more flexible to reduce these negative effects. This is the first study to measure the cytotoxicity of these composites via the survival of rat cells. Cubes of carbon fiber/flax fiber/epoxy and glass fiber/flax fiber/epoxy had better cell survival vs. Kevlar fiber/flax fiber/epoxy (57% and 58% vs. 50%). Layers and powders made of carbon fiber/epoxy and glass fiber/epoxy had higher cell survival than Kevlar fiber/epoxy (96%–100% and 100% vs. 39%–90%). The presence of flax fibers usually decreased cell survival. Thus, carbon and glass fiber composites (with or without flax fibers), but not Kevlar fiber composites (with or without flax fibers), may potentially be used for bone fracture plates.
- 10 May 2024
- Published by IOP Publishing in Biomedical Materials
- Vol. 19 (4) , 041001
Cytotoxicity of novel hybrid composite materials for making bone fracture plates
Bone fracture plates are usually made from steel or titanium, which are much stiffer than cortical bone. This may cause bone ‘stress shielding’ (i.e. bone resorption leading to plate loosening) and delayed fracture healing (i.e. fracture motion is less than needed to stimulate callus formation at the fracture). Thus, the authors previously designed, fabricated, and mechanically tested novel ‘hybrid’ composites made from inorganic and organic materials as potential bone fracture plates that are more flexible to reduce these negative effects. This is the first study to measure the cytotoxicity of these composites via the survival of rat cells. Cubes of carbon fiber/flax fiber/epoxy and glass fiber/flax fiber/epoxy had better cell survival vs. Kevlar fiber/flax fiber/epoxy (57% and 58% vs. 50%). Layers and powders made of carbon fiber/epoxy and glass fiber/epoxy had higher cell survival than Kevlar fiber/epoxy (96%–100% and 100% vs. 39%–90%). The presence of flax fibers usually decreased cell survival. Thus, carbon and glass fiber composites (with or without flax fibers), but not Kevlar fiber composites (with or without flax fibers), may potentially be used for bone fracture plates.
- Open Access
- 15 April 2024
- Published by Wolters Kluwer Health in OTA International
- Vol. 7 (2) , e333
Fasciotomy and rate of amputation after tibial fracture in adults: a population-based cohort study
Objectives: Limb amputation is a possible outcome of acute compartment syndrome. We undertook this study to investigate the occurrence of fasciotomy and amputation in patients with tibial fractures in the Ontario adult population, aiming to evaluate variables that may be associated with each of these outcomes. Design: Retrospective, population-based cohort study (April 1, 2003–March 31, 2016). Setting: Canadian province of Ontario. Participants: Patients with tibial fracture, aged 14 years and older. Intervention(s): Fasciotomy after tibial fracture. Main Outcome(s) and Measure(s): The primary outcomes were fasciotomy and amputation within 1 year of fasciotomy. Secondary outcomes included repeat surgery, new-onset renal failure, and mortality, all within 30 days of fasciotomy. Results: We identified 76,299 patients with tibial fracture; the mean (SD) age was 47 (21) years. Fasciotomy was performed in 1303 patients (1.7%); of these, 76% were male and 24% female. Patients who were younger, male, or experienced polytrauma were significantly more likely to undergo fasciotomy. Limb amputation occurred in 4.3% of patients undergoing fasciotomy, as compared with 0.5% in those without fasciotomy; older age, male sex, presence of polytrauma, and fasciotomy were associated with an increased risk of amputation (age odds ratio [OR] of 1.03 [95% CI, 1.02–1.03], P < 0.0001; sex OR of 2.04 [95% CI, 1.63–2.55], P < 0.0001; polytrauma OR of 9.37 [95% CI, 7.64–11.50], P < 0.0001; fasciotomy OR of 4.35 [95% CI, 3.21–5.90], P < 0.0001), as well as repeat surgery within 30 days (sex OR of 1.54 [95% CI, 1.14–2.07], P = 0.0053; polytrauma OR of 4.24 [95% CI, 3.33–5.38], P < 0.0001). Conclusions: Among tibial fracture patients, those who were male and who experienced polytrauma were at significantly higher risk of undergoing fasciotomy and subsequent amputation. Fasciotomy was also significantly associated with risk of amputation, a finding that is likely reflective of the severity of the initial injury.
- 15 April 2024
- Published by Wolters Kluwer Health in OTA International
- Vol. 7 (2) , e333
Open AccessFasciotomy and rate of amputation after tibial fracture in adults: a population-based cohort study
Objectives: Limb amputation is a possible outcome of acute compartment syndrome. We undertook this study to investigate the occurrence of fasciotomy and amputation in patients with tibial fractures in the Ontario adult population, aiming to evaluate variables that may be associated with each of these outcomes. Design: Retrospective, population-based cohort study (April 1, 2003–March 31, 2016). Setting: Canadian province of Ontario. Participants: Patients with tibial fracture, aged 14 years and older. Intervention(s): Fasciotomy after tibial fracture. Main Outcome(s) and Measure(s): The primary outcomes were fasciotomy and amputation within 1 year of fasciotomy. Secondary outcomes included repeat surgery, new-onset renal failure, and mortality, all within 30 days of fasciotomy. Results: We identified 76,299 patients with tibial fracture; the mean (SD) age was 47 (21) years. Fasciotomy was performed in 1303 patients (1.7%); of these, 76% were male and 24% female. Patients who were younger, male, or experienced polytrauma were significantly more likely to undergo fasciotomy. Limb amputation occurred in 4.3% of patients undergoing fasciotomy, as compared with 0.5% in those without fasciotomy; older age, male sex, presence of polytrauma, and fasciotomy were associated with an increased risk of amputation (age odds ratio [OR] of 1.03 [95% CI, 1.02–1.03], P < 0.0001; sex OR of 2.04 [95% CI, 1.63–2.55], P < 0.0001; polytrauma OR of 9.37 [95% CI, 7.64–11.50], P < 0.0001; fasciotomy OR of 4.35 [95% CI, 3.21–5.90], P < 0.0001), as well as repeat surgery within 30 days (sex OR of 1.54 [95% CI, 1.14–2.07], P = 0.0053; polytrauma OR of 4.24 [95% CI, 3.33–5.38], P < 0.0001). Conclusions: Among tibial fracture patients, those who were male and who experienced polytrauma were at significantly higher risk of undergoing fasciotomy and subsequent amputation. Fasciotomy was also significantly associated with risk of amputation, a finding that is likely reflective of the severity of the initial injury.
- Open Access
- 8 November 2022
- Published by CMA Impact Inc. in Canadian Journal Of Surgery
- Vol. 65 (6) , E739-E748
Evaluation of a tiered operating room strategy at an academic centre: comparing high-efficiency and conventional operating rooms
Background: Wait times for many elective orthopedic surgical procedures in Ontario have become unacceptably long and substantially exceed the recommended guidelines. As a consequence, many patients experience chronic pain, disability and other poor health outcomes. The purpose of this study was to test a novel, resource-saving redesign of outpatient operating room (OR) services, based on tiered grouping of surgical cases, to maximize health benefits for patients while improving efficiency and decreasing wait times. Methods: This prospective cohort study enrolled adult patients scheduled to undergo unilateral lower limb procedures that had a low requirement for surgical resources and did not require admission to the hospital (ambulatory surgical services) at an academic hospital. Patients were randomly assigned to a conventional OR group or a high-efficiency (tiered) OR group, in which the intensity of surgical, anesthesia and nursing resources was matched to the procedure and the patient’s health status. The tiered OR made use of local anesthesia and a block room rather than general anesthesia. Primary outcomes were costs of surgical services provided and patient health outcomes; secondary outcomes were patient and staff satisfaction with each OR setup. Results: The costs associated with the high-efficiency OR were 60% lower than those associated with the conventional OR (this was primarily due to the streamlining of OR care and elimination of the need to use a postanesthetic care unit), with the same or equivalent patient health outcomes. No differences in patient and staff satisfaction were found between the 2 setups. Conclusion: The use of tiered, ambulatory services for elective orthopedic surgery does not compromise health outcomes and patient satisfaction, and it is associated with substantial cost savings. Contexte: En Ontario, les temps d’attentes de plusieurs interventions en chirurgie orthopédique non urgentes s’allongent déraisonnablement et excèdent largement ceux des lignes directrices. Par conséquent, plusieurs patients doivent vivre avec de la douleur chronique, une invalidité ou d’autres problèmes de santé. Le but de cette étude était de mettre à l’essai une nouvelle configuration des services en salle d’opération pour les patients ambulatoires qui permettrait d’économiser les ressources et qui se fonderait sur un regroupement des cas chirurgicaux en échelons afin de maximiser les bienfaits pour la santé des patients tout en améliorant l’efficacité et en diminuant les temps d’attente. Méthodes: Dans cette étude de cohorte prospective, les patients adultes participants ont subi dans un hôpital universitaire une intervention chirurgicale unilatérale à un membre inférieur demandant peu de ressources et ne nécessitant pas d’hospitalisation (services de chirurgie ambulatoire). Les patients étaient répartis aléatoirement en 2 groupes : 1 groupe était assigné à une salle d’opération classique, et l’autre à une salle à rendement élevé (interventions échelonnées), où l’intensité des ressources allouées à l’intervention, à l’anesthésie et au personnel infirmier correspondait au type d’intervention et à l’état de santé du patient. La salle d’opération par échelons avait la possibilité d’utiliser l’anesthésie locale dans une salle d’anesthésie locorégionale plutôt qu’une anesthésie générale. Les paramètres principaux de l’étude étaient le coût des services chirurgicaux fournis et les résultats cliniques des patients; le paramètre secondaire était la satisfaction des patients et du personnel de chaque configuration de la salle d’opération. Résultats: Les coûts associés aux salles d’opération à rendement élevé étaient inférieurs de 60 % à ceux associés aux salles d’opération classiques (cette différence s’expliquerait par la simplification des soins en salle d’opération et l’élimination du besoin d’une salle de réveil), pour des résultats cliniques similaires ou équivalents. Aucune différence dans la satisfaction des patients et du personnel n’a été observée entre les 2 configurations. Conclusion: Le recours à l’échelonnage des services ambulatoires pour l’exécution des interventions en chirurgie orthopédique non urgentes ne compromet ni les résultats cliniques ni la satisfaction des patients et s’accompagne d’une réduction substantielle des coûts.
- 8 November 2022
- Published by CMA Impact Inc. in Canadian Journal Of Surgery
- Vol. 65 (6) , E739-E748
Open AccessEvaluation of a tiered operating room strategy at an academic centre: comparing high-efficiency and conventional operating rooms
Background: Wait times for many elective orthopedic surgical procedures in Ontario have become unacceptably long and substantially exceed the recommended guidelines. As a consequence, many patients experience chronic pain, disability and other poor health outcomes. The purpose of this study was to test a novel, resource-saving redesign of outpatient operating room (OR) services, based on tiered grouping of surgical cases, to maximize health benefits for patients while improving efficiency and decreasing wait times. Methods: This prospective cohort study enrolled adult patients scheduled to undergo unilateral lower limb procedures that had a low requirement for surgical resources and did not require admission to the hospital (ambulatory surgical services) at an academic hospital. Patients were randomly assigned to a conventional OR group or a high-efficiency (tiered) OR group, in which the intensity of surgical, anesthesia and nursing resources was matched to the procedure and the patient’s health status. The tiered OR made use of local anesthesia and a block room rather than general anesthesia. Primary outcomes were costs of surgical services provided and patient health outcomes; secondary outcomes were patient and staff satisfaction with each OR setup. Results: The costs associated with the high-efficiency OR were 60% lower than those associated with the conventional OR (this was primarily due to the streamlining of OR care and elimination of the need to use a postanesthetic care unit), with the same or equivalent patient health outcomes. No differences in patient and staff satisfaction were found between the 2 setups. Conclusion: The use of tiered, ambulatory services for elective orthopedic surgery does not compromise health outcomes and patient satisfaction, and it is associated with substantial cost savings. Contexte: En Ontario, les temps d’attentes de plusieurs interventions en chirurgie orthopédique non urgentes s’allongent déraisonnablement et excèdent largement ceux des lignes directrices. Par conséquent, plusieurs patients doivent vivre avec de la douleur chronique, une invalidité ou d’autres problèmes de santé. Le but de cette étude était de mettre à l’essai une nouvelle configuration des services en salle d’opération pour les patients ambulatoires qui permettrait d’économiser les ressources et qui se fonderait sur un regroupement des cas chirurgicaux en échelons afin de maximiser les bienfaits pour la santé des patients tout en améliorant l’efficacité et en diminuant les temps d’attente. Méthodes: Dans cette étude de cohorte prospective, les patients adultes participants ont subi dans un hôpital universitaire une intervention chirurgicale unilatérale à un membre inférieur demandant peu de ressources et ne nécessitant pas d’hospitalisation (services de chirurgie ambulatoire). Les patients étaient répartis aléatoirement en 2 groupes : 1 groupe était assigné à une salle d’opération classique, et l’autre à une salle à rendement élevé (interventions échelonnées), où l’intensité des ressources allouées à l’intervention, à l’anesthésie et au personnel infirmier correspondait au type d’intervention et à l’état de santé du patient. La salle d’opération par échelons avait la possibilité d’utiliser l’anesthésie locale dans une salle d’anesthésie locorégionale plutôt qu’une anesthésie générale. Les paramètres principaux de l’étude étaient le coût des services chirurgicaux fournis et les résultats cliniques des patients; le paramètre secondaire était la satisfaction des patients et du personnel de chaque configuration de la salle d’opération. Résultats: Les coûts associés aux salles d’opération à rendement élevé étaient inférieurs de 60 % à ceux associés aux salles d’opération classiques (cette différence s’expliquerait par la simplification des soins en salle d’opération et l’élimination du besoin d’une salle de réveil), pour des résultats cliniques similaires ou équivalents. Aucune différence dans la satisfaction des patients et du personnel n’a été observée entre les 2 configurations. Conclusion: Le recours à l’échelonnage des services ambulatoires pour l’exécution des interventions en chirurgie orthopédique non urgentes ne compromet ni les résultats cliniques ni la satisfaction des patients et s’accompagne d’une réduction substantielle des coûts.
- 22 June 2019
- Published by Wiley in Microcirculation
- Vol. 26 (7) , e12577
Carbon monoxide‐releasing molecule‐3 (CORM‐3) offers protection in an in vitro model of compartment syndrome
Objective Limb compartment syndrome (CS), a complication of trauma, results in muscle necrosis and cell death; ischemia and inflammation contribute to microvascular dysfunction and parenchymal injury. Carbon monoxide releasing molecule‐3 (CORM‐3) has been shown to protect microvascular perfusion and reduce inflammation in animal models of CS. The purpose of the study was to test the effect of CORM‐3 in human in vitro CS model, allowing exploration of the mechanism(s) of CO protection and potential development of pharmacologic treatment. Methods Confluent human vascular endothelial cells (HUVECs) were stimulated for 6 hours with serum isolated from CS patients. Intracellular oxidative stress (production of reactive oxygen species (ROS)) apoptosis, trans‐endothelial resistance (TEER), polymorphonuclear leukocyte (PMN) activation and transmigration across the monolayer in response to the CS stimulus were assessed. All experiments were performed in the presence of CORM‐3 (100μM), or its inactive form, iCORM‐3. Results CS serum induced a significant increase in ROS, apoptosis and endothelial monolayer breakdown; it also increased PMN superoxide production, leukocyte rolling and adhesion/transmigration. CORM‐3 completely prevented CS‐induced ROS production, apoptosis, PMN adhesion, rolling and transmigration, while improving monolayer integrity. Conclusion CORM‐3 offers potent anti‐oxidant and anti‐inflammatory effects, and may have a potential application to patients at risk of developing CS.
- 22 June 2019
- Published by Wiley in Microcirculation
- Vol. 26 (7) , e12577
Carbon monoxide‐releasing molecule‐3 (CORM‐3) offers protection in an in vitro model of compartment syndrome
Objective Limb compartment syndrome (CS), a complication of trauma, results in muscle necrosis and cell death; ischemia and inflammation contribute to microvascular dysfunction and parenchymal injury. Carbon monoxide releasing molecule‐3 (CORM‐3) has been shown to protect microvascular perfusion and reduce inflammation in animal models of CS. The purpose of the study was to test the effect of CORM‐3 in human in vitro CS model, allowing exploration of the mechanism(s) of CO protection and potential development of pharmacologic treatment. Methods Confluent human vascular endothelial cells (HUVECs) were stimulated for 6 hours with serum isolated from CS patients. Intracellular oxidative stress (production of reactive oxygen species (ROS)) apoptosis, trans‐endothelial resistance (TEER), polymorphonuclear leukocyte (PMN) activation and transmigration across the monolayer in response to the CS stimulus were assessed. All experiments were performed in the presence of CORM‐3 (100μM), or its inactive form, iCORM‐3. Results CS serum induced a significant increase in ROS, apoptosis and endothelial monolayer breakdown; it also increased PMN superoxide production, leukocyte rolling and adhesion/transmigration. CORM‐3 completely prevented CS‐induced ROS production, apoptosis, PMN adhesion, rolling and transmigration, while improving monolayer integrity. Conclusion CORM‐3 offers potent anti‐oxidant and anti‐inflammatory effects, and may have a potential application to patients at risk of developing CS.
- Open Access
- 1 December 2018
- Published by Wolters Kluwer Health in OTA International
- Vol. 1 (3) , e011
Compartment syndrome-induced muscle injury is diminished by the neutralization of pro-inflammatory cytokines
Objectives: Compartment syndrome (CS) is one of the most devastating consequences of musculoskeletal trauma. The pathophysiology of CS includes elevation of intracompartmental pressure (ICP), causing damage to the microcirculation, decreased oxygen delivery, tissue anoxia, and cell death. CS is a combined ischemic and inflammatory condition that induces the systemic inflammatory cascade. In complete ischemia, within the first hour of reperfusion, a peak in the pro-inflammatory cytokine, tumor necrosis factor alpha (TNF-α) has been previously reported. The purpose of this study was to examine the suspected systemic inflammatory cytokine/chemokine release in response to CS, and to evaluate the microvascular dysfunction, tissue injury, and inflammatory response following the neutralization of pro-inflammatory cytokines TNF-α and/or interleukin-1 beta (IL-1β). Methods: Twenty-eight male Wistar rats were randomly assigned into 5 groups: Sham (no CS), CS (with isotype control), CS+TNF-α neutralizing antibody (NA), CS+IL-1β NA, CS+Combo (both TNF-α and IL-1β NA). CS was induced by elevation of ICP above 30 mm Hg through an infusion of isotonic saline into the anterior compartment of the hind limb for 2 hours; NA were administered just prior to fasciotomy. Microvascular perfusion, cellular tissue injury, and inflammatory response within the extensor digitorum longus muscle were assessed using intravital video microscopy for 45 minutes after fasciotomy. Systemic levels of 24 different cytokines/chemokines were also measured, using the xMAP Luminex technology. Results: Of the 24 cytokines/chemokines sampled, 6 were significantly elevated from their baseline levels, and included the pro-inflammatory cytokines TNF-α, IL-1β, growth-related oncogene/keratinocyte chemoattractant (GRO/KC), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1α), and the anti-inflammatory cytokine IL-10. CS resulted in a significant decrease in microvascular perfusion, from 75 ± 2% continuously perfused capillaries in the sham to 31 ± 4% in CS (P < .001), a significant increase in tissue injury (0.33 ± 0.4 versus 0.04 ± 0.01 in sham) and leukocyte activation (14 ± 2 adherent leukocytes/1000 μm2 versus 2 ± 1 adherent leukocytes/100 μm2 in sham, P < .001). CS-associated tissue injury was significantly decreased with TNF-α neutralization (P < .05), both when administered alone or in combination with IL-1β (P < .05). Additionally, TNF-α neutralization blocked CS-associated leukocyte activation (P < .05); IL-1β neutralization also diminished leukocyte adhesion (P < .05). Perfusion remained virtually unchanged in CS animals treated with NA (36 ± 4%, 32 ± 3% and 30 ± 2% in CS+TNF-α, CS+IL-1β and CS+Combo groups, respectively). Conclusion: The results of this study indicate that CS induces a systemic inflammation, as evidenced by upregulation of inflammatory cytokines/chemokines in circulation. Neutralization of TNF-α led to a significant reduction in tissue injury; however, it had no effect on the CS-induced microvascular dysfunction. This suggests a distinct role of TNF-α in the pathophysiology of muscle injury in CS.
- 1 December 2018
- Published by Wolters Kluwer Health in OTA International
- Vol. 1 (3) , e011
Open AccessCompartment syndrome-induced muscle injury is diminished by the neutralization of pro-inflammatory cytokines
Objectives: Compartment syndrome (CS) is one of the most devastating consequences of musculoskeletal trauma. The pathophysiology of CS includes elevation of intracompartmental pressure (ICP), causing damage to the microcirculation, decreased oxygen delivery, tissue anoxia, and cell death. CS is a combined ischemic and inflammatory condition that induces the systemic inflammatory cascade. In complete ischemia, within the first hour of reperfusion, a peak in the pro-inflammatory cytokine, tumor necrosis factor alpha (TNF-α) has been previously reported. The purpose of this study was to examine the suspected systemic inflammatory cytokine/chemokine release in response to CS, and to evaluate the microvascular dysfunction, tissue injury, and inflammatory response following the neutralization of pro-inflammatory cytokines TNF-α and/or interleukin-1 beta (IL-1β). Methods: Twenty-eight male Wistar rats were randomly assigned into 5 groups: Sham (no CS), CS (with isotype control), CS+TNF-α neutralizing antibody (NA), CS+IL-1β NA, CS+Combo (both TNF-α and IL-1β NA). CS was induced by elevation of ICP above 30 mm Hg through an infusion of isotonic saline into the anterior compartment of the hind limb for 2 hours; NA were administered just prior to fasciotomy. Microvascular perfusion, cellular tissue injury, and inflammatory response within the extensor digitorum longus muscle were assessed using intravital video microscopy for 45 minutes after fasciotomy. Systemic levels of 24 different cytokines/chemokines were also measured, using the xMAP Luminex technology. Results: Of the 24 cytokines/chemokines sampled, 6 were significantly elevated from their baseline levels, and included the pro-inflammatory cytokines TNF-α, IL-1β, growth-related oncogene/keratinocyte chemoattractant (GRO/KC), monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1 alpha (MIP-1α), and the anti-inflammatory cytokine IL-10. CS resulted in a significant decrease in microvascular perfusion, from 75 ± 2% continuously perfused capillaries in the sham to 31 ± 4% in CS (P < .001), a significant increase in tissue injury (0.33 ± 0.4 versus 0.04 ± 0.01 in sham) and leukocyte activation (14 ± 2 adherent leukocytes/1000 μm2 versus 2 ± 1 adherent leukocytes/100 μm2 in sham, P < .001). CS-associated tissue injury was significantly decreased with TNF-α neutralization (P < .05), both when administered alone or in combination with IL-1β (P < .05). Additionally, TNF-α neutralization blocked CS-associated leukocyte activation (P < .05); IL-1β neutralization also diminished leukocyte adhesion (P < .05). Perfusion remained virtually unchanged in CS animals treated with NA (36 ± 4%, 32 ± 3% and 30 ± 2% in CS+TNF-α, CS+IL-1β and CS+Combo groups, respectively). Conclusion: The results of this study indicate that CS induces a systemic inflammation, as evidenced by upregulation of inflammatory cytokines/chemokines in circulation. Neutralization of TNF-α led to a significant reduction in tissue injury; however, it had no effect on the CS-induced microvascular dysfunction. This suggests a distinct role of TNF-α in the pathophysiology of muscle injury in CS.
- 1 May 2018
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 46 (5) , e469-e472
Systemic Administration of Carbon Monoxide–Releasing Molecule-3 Protects the Skeletal Muscle in Porcine Model of Compartment Syndrome
Objectives: Acute limb compartment syndrome, a complication of musculoskeletal trauma, results in muscle necrosis and cell death. Carbon monoxide, liberated from the carbon monoxide–releasing molecule-3, has been shown protective in a rat model of compartment syndrome. The purpose of this study was to test the effect of carbon monoxide–releasing molecule-3 in a preclinical large animal model of compartment syndrome, with the ultimate goal of developing a pharmacologic adjunct treatment for compartment syndrome. Design: Animal research study. Setting: Basic research laboratory in a hospital setting. Subjects: Male Yorkshire-Landrace pigs (50–60 kg). Interventions: Pigs underwent 6 hours of intracompartmental pressure elevation by infusing fluid into the anterior compartment of the right hind limb. Carbon monoxide–releasing molecule-3 was administered systemically (2 mg/kg, IV) at fasciotomy, followed by 3-hour reperfusion. Measurements and Main Results: Muscle perfusion, inflammation, injury, and apoptosis were assessed in the skeletal muscle. Systemic leukocyte activation was assessed during compartment syndrome and reperfusion. Elevation of hind limb intracompartmental pressure resulted in significant microvascular perfusion deficits (44% ± 1% continuously perfused capillaries in compartment syndrome vs 76% ± 4% in sham; p < 0.001), increased tissue injury (ethidium bromide/bisbenzimide of 0.31 ± 0.07 in compartment syndrome vs 0.17 ± 0.03 in sham; p < 0.05), apoptosis (fluorescence in vivo/bisbenzimide of 0.26 ± 0.06 in compartment syndrome vs 0.13 ± 0.03 in sham; p < 0.05), and systemic leukocyte activation (14.7 relative luminescence units/106 polymorphonuclear leukocytes in compartment syndrome vs 1.0 ± 0.1 in baseline; p < 0.001). Systemic application of carbon monoxide–releasing molecule-3 at fasciotomy increased the number of continuously perfused capillaries (68% ± 3%; p < 0.001), diminished tissue injury (ethidium bromide/bisbenzimide of 0.13 ± 0.04; p < 0.05), apoptosis (fluorescence in vivo/bisbenzimide of 0.12 ± 0.03; p < 0.05), and blocked systemic leukocyte activation (3.9 ± 0.3 relative luminescence unit/106 polymorphonuclear leukocytes; p < 0.001). Conclusions: Administration of carbon monoxide–releasing molecule-3 at fasciotomy offered protection against compartment syndrome–induced microvascular perfusion deficit, tissue injury, and systemic leukocyte activation. The data suggest the potential therapeutic application of carbon monoxide–releasing molecule-3 to patients at risk of developing compartment syndrome.
- 1 May 2018
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 46 (5) , e469-e472
Systemic Administration of Carbon Monoxide–Releasing Molecule-3 Protects the Skeletal Muscle in Porcine Model of Compartment Syndrome
Objectives: Acute limb compartment syndrome, a complication of musculoskeletal trauma, results in muscle necrosis and cell death. Carbon monoxide, liberated from the carbon monoxide–releasing molecule-3, has been shown protective in a rat model of compartment syndrome. The purpose of this study was to test the effect of carbon monoxide–releasing molecule-3 in a preclinical large animal model of compartment syndrome, with the ultimate goal of developing a pharmacologic adjunct treatment for compartment syndrome. Design: Animal research study. Setting: Basic research laboratory in a hospital setting. Subjects: Male Yorkshire-Landrace pigs (50–60 kg). Interventions: Pigs underwent 6 hours of intracompartmental pressure elevation by infusing fluid into the anterior compartment of the right hind limb. Carbon monoxide–releasing molecule-3 was administered systemically (2 mg/kg, IV) at fasciotomy, followed by 3-hour reperfusion. Measurements and Main Results: Muscle perfusion, inflammation, injury, and apoptosis were assessed in the skeletal muscle. Systemic leukocyte activation was assessed during compartment syndrome and reperfusion. Elevation of hind limb intracompartmental pressure resulted in significant microvascular perfusion deficits (44% ± 1% continuously perfused capillaries in compartment syndrome vs 76% ± 4% in sham; p < 0.001), increased tissue injury (ethidium bromide/bisbenzimide of 0.31 ± 0.07 in compartment syndrome vs 0.17 ± 0.03 in sham; p < 0.05), apoptosis (fluorescence in vivo/bisbenzimide of 0.26 ± 0.06 in compartment syndrome vs 0.13 ± 0.03 in sham; p < 0.05), and systemic leukocyte activation (14.7 relative luminescence units/106 polymorphonuclear leukocytes in compartment syndrome vs 1.0 ± 0.1 in baseline; p < 0.001). Systemic application of carbon monoxide–releasing molecule-3 at fasciotomy increased the number of continuously perfused capillaries (68% ± 3%; p < 0.001), diminished tissue injury (ethidium bromide/bisbenzimide of 0.13 ± 0.04; p < 0.05), apoptosis (fluorescence in vivo/bisbenzimide of 0.12 ± 0.03; p < 0.05), and blocked systemic leukocyte activation (3.9 ± 0.3 relative luminescence unit/106 polymorphonuclear leukocytes; p < 0.001). Conclusions: Administration of carbon monoxide–releasing molecule-3 at fasciotomy offered protection against compartment syndrome–induced microvascular perfusion deficit, tissue injury, and systemic leukocyte activation. The data suggest the potential therapeutic application of carbon monoxide–releasing molecule-3 to patients at risk of developing compartment syndrome.
- 16 February 2017
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 66 (6) , 1864-1871
Systemic application of carbon monoxide-releasing molecule 3 protects skeletal muscle from ischemia-reperfusion injury
- 16 February 2017
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 66 (6) , 1864-1871
Systemic application of carbon monoxide-releasing molecule 3 protects skeletal muscle from ischemia-reperfusion injury
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , S40
Carbon Monoxide and Hydrogen Sulphide as Possible Therapeutics for Abdominal Compartment Syndrome: A Rat Model
- 1 October 2016
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 223 (4) , S40
Carbon Monoxide and Hydrogen Sulphide as Possible Therapeutics for Abdominal Compartment Syndrome: A Rat Model
- 21 April 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 197 (2) , 398-404
Hepatic microvascular changes in rat abdominal compartment syndrome
- 21 April 2015
- Published by Elsevier in Journal of Surgical Research
- Vol. 197 (2) , 398-404
Hepatic microvascular changes in rat abdominal compartment syndrome
- 1 November 2014
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 28 (11) , e263-e268
The Severity of Microvascular Dysfunction Due to Compartment Syndrome Is Diminished by the Systemic Application of CO-Releasing Molecule-3
Objectives: To examine the protective effects of carbon monoxide (CO), liberated from a novel CO-releasing molecule (CORM-3), on the function of compartment syndrome (CS)–challenged muscle in a rodent model, thus providing for a potential development of a pharmacologic adjunctive treatment for CS. Methods: Wistar rats were randomized into 4 groups: sham (no CS), CS, CS with inactive CORM-3 (iCORM-3), and CS + CORM-3 (10 mg/kg intraperitoneally). CS was induced by elevation of intracompartmental pressure to 30 mm Hg through an infusion of isotonic saline into the anterior compartment of the hind limb for 2 hours. Both CORM-3 and iCORM-3 were injected immediately after fasciotomy. Microvascular perfusion, cellular tissue injury, and inflammatory response within the extensor digitorum longus muscle were assessed using intravital video microscopy 45 minutes after fasciotomy. Systemic levels of tumor necrosis factor alpha (TNF-α) were also measured. Results: Elevation of intracompartmental pressure resulted in significant microvascular perfusion deficits (23% ± 2% continuously perfused capillaries in CS vs. 76% ± 4% in sham, P < 0.0001; 55% ± 2% nonperfused capillaries in CS vs. 13% ± 2% in sham, P < 0.0001), significant increase in tissue injury (ethidium bromide/bisbenzimide of 0.31 ± 0.05 in CS vs. 0.05 ± 0.03 in sham, P < 0.0001) and adherent leukocytes (13.7 ± 0.9 in CS vs. 1.8 ± 0.5 in sham, P < 0.0001), and a progressive rise in systemic TNF-α. CORM-3 (but not iCORM-3) treatment restored the number of continuously perfused capillaries (57% ± 5%, P < 0.001), diminished tissue injury (ethidium bromide/bisbenzimide of 0.07 ± 0.01, P < 0.001), reversed the CS-associated rise in TNF-α, and decreased leukocyte adherence (0.6 ± 0.3, P < 0.001). Conclusions: CORM-3 displays a potent protective/anti-inflammatory action in an experimental model of CS, suggesting a potential therapeutic application to patients at risk of developing CS.
- 1 November 2014
- Published by Wolters Kluwer Health in Journal of Orthopaedic Trauma
- Vol. 28 (11) , e263-e268
The Severity of Microvascular Dysfunction Due to Compartment Syndrome Is Diminished by the Systemic Application of CO-Releasing Molecule-3
Objectives: To examine the protective effects of carbon monoxide (CO), liberated from a novel CO-releasing molecule (CORM-3), on the function of compartment syndrome (CS)–challenged muscle in a rodent model, thus providing for a potential development of a pharmacologic adjunctive treatment for CS. Methods: Wistar rats were randomized into 4 groups: sham (no CS), CS, CS with inactive CORM-3 (iCORM-3), and CS + CORM-3 (10 mg/kg intraperitoneally). CS was induced by elevation of intracompartmental pressure to 30 mm Hg through an infusion of isotonic saline into the anterior compartment of the hind limb for 2 hours. Both CORM-3 and iCORM-3 were injected immediately after fasciotomy. Microvascular perfusion, cellular tissue injury, and inflammatory response within the extensor digitorum longus muscle were assessed using intravital video microscopy 45 minutes after fasciotomy. Systemic levels of tumor necrosis factor alpha (TNF-α) were also measured. Results: Elevation of intracompartmental pressure resulted in significant microvascular perfusion deficits (23% ± 2% continuously perfused capillaries in CS vs. 76% ± 4% in sham, P < 0.0001; 55% ± 2% nonperfused capillaries in CS vs. 13% ± 2% in sham, P < 0.0001), significant increase in tissue injury (ethidium bromide/bisbenzimide of 0.31 ± 0.05 in CS vs. 0.05 ± 0.03 in sham, P < 0.0001) and adherent leukocytes (13.7 ± 0.9 in CS vs. 1.8 ± 0.5 in sham, P < 0.0001), and a progressive rise in systemic TNF-α. CORM-3 (but not iCORM-3) treatment restored the number of continuously perfused capillaries (57% ± 5%, P < 0.001), diminished tissue injury (ethidium bromide/bisbenzimide of 0.07 ± 0.01, P < 0.001), reversed the CS-associated rise in TNF-α, and decreased leukocyte adherence (0.6 ± 0.3, P < 0.001). Conclusions: CORM-3 displays a potent protective/anti-inflammatory action in an experimental model of CS, suggesting a potential therapeutic application to patients at risk of developing CS.